Pièce : CHEO RI
Bureau : 613-737-7600 poste 3223
Courriel professionnel : firstname.lastname@example.org
Research Practice Areas:
- Rare Disease
Dr. Boycott's research, bringing together clinical medicine with basic science, is focused on elucidating the molecular pathogenesis of rare inherited neurological diseases using next-generation sequencing approaches. She is the Lead Investigator of the nation consortium FORGE Canada ('Finding of Rare Disease Genes in Canada') project which is investigating the molecular etiology of almost 200 rare pediatric diseases. Related to translating these discoveries to the clinic, Dr. Boycott is interested in facilitating incorporation of next-generation sequencing approaches to routine diagnostics and patient care.
- Chandree Beaulieu - Project Manager
- Alex Mackenzie - Principal Investigator, Apoptosis Research Centre,
- Megan Vanstone - Research Coordinator, NeuroRare Research Unit
Dr. Boycott is a Clinical Geneticist at the Children's Hospital of Eastern Ontario and Investigator at the CHEO Research Institute. She is an Associate Professor and holds a Tier II Research Chair from the Faculty of Medicine in Neurogenetics at the University of Ottawa. Dr. Boycott completed the Royal College of Physician and Surgeons training program in Medical Genetics at the University of Calgary in 2005, after completing medical school at the University of Calgary in 2000. She received her PhD in Medical Genetics in 1997 from the University of Calgary.
Dr. Boycott has been named as Co-Chair of the Diagnostics Scientific Committee for the International Rare Diseases Research Consortium (IRDiRC). In 2011, Dr. Boycott was named Distinguished Young Professor of the Year by the Faculty of Medicine at the University of Ottawa
Mendelian diseases, rare diseases, neurogenetics, gene identification, next-generation sequencing